Form 4 Filing for Thomas Sellig

Thomas Sellig, a director at ACHIEVE LIFE SCIENCES, INC., acquired 25,000 stock options and 16,700 Restricted Stock Units (RSUs) on July 27, 2026. The stock options have an exercise price of $6.18 and vest fully on July 27, 2027, or the date before the 2027 annual meeting, contingent upon continued service. Each RSU represents a right to one share of common stock and vests under the same conditions as the stock options. These transactions are reported on a Form 4 filing, with Mr. Sellig holding direct ownership after these acquisitions.